申请人:Baeschlin Daniel Kaspar
公开号:US20090192138A1
公开(公告)日:2009-07-30
The invention provides novel deazaxanthine and deazahypoxanthine compounds. The compounds may be useful in the therapy of diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.
本发明提供了新型的脱氮黄质和脱氮次黄嘌呤化合物。这些化合物可用于治疗与二肽基肽酶-IV(DPP-IV)有关的疾病和病况。